Signals from fibronectin-binding integrins promote neural crest cell motility during development in part through protein-tyrosine kinase (PTK) activation. Neuroblastoma (NB) is a neural crest malignancy with high metastatic potential. We find that a4 and a5 integrins are present in late-stage NB tumors and cell lines derived thereof. To determine the signaling connections promoting either a4b1-or a5b1-initiated NB cell motility, pharmacological, dominant negative and short-hairpin RNA (shRNA) inhibitory approaches were undertaken. shRNA knockdown revealed that a5b1-stimulated NB motility is dependent upon focal adhesion kinase (FAK) PTK, Src PTK and p130Cas adapter protein expression. Cell reconstitution showed that FAK catalytic activity is required for a5b1-stimulated Src activation in part through direct FAK phosphorylation of Src at Tyr-418. Alternatively, a4b1-stimulated NB cell motility is dependent upon Src and p130Cas but FAK is not essential. Catalytically inactive receptor protein-tyrosine phosphatasea overexpression inhibited a4b1-stimulated NB motility and Src activation consistent with a4-regulated Src activity occurring through Src Tyr-529 dephosphorylation. In a4 shRNA-expressing NB cells, a4b1-stimulated Src activation and NB cell motility were rescued by wild type but not cytoplasmic domain-truncated a4 re-expression. These studies, supported by results using reconstituted fibroblasts, reveal that a4b1-mediated Src activation is mechanistically distinct from FAK-mediated Src activation during a5b1-mediated NB migration and support the evaluation of inhibitors to a4, Src and FAK in the control of NB tumor progression.
Introduction
Neuroblastoma (NB) represents 8-10% of childhood cancers (Brodeur, 2003) and originates from precursor cells of the peripheral sympathetic nervous system. NB metastatic spread is a major obstacle to clinical treatment. Integrins mediate cell-extracellular matrix interactions that modulate cell adhesion, migration, survival and growth (Guo and Giancotti, 2004) . Unligated integrins negatively effect NB survival and metastasis (Stupack et al., 2006) whereas integrinstimulated signaling cascades controlling NB cell motility remain largely undefined.
Fibronectin (FN) signals can facilitate tumor development (Ruoslahti, 1999) . a5b1 is a classical FN receptor with binding through FN repeats III-9 and III-10 (Pankov and Yamada, 2002) . Upon cell binding and spreading on FN, focal adhesion kinase (FAK) is recruited to sites of a5b1 clustering through FAK C-terminal domain interactions with b1-integrin-binding proteins, such as talin and paxillin (Parsons, 2003) . FN-stimulated FAK activation increases FAK Tyr-397 phosphorylation (pY397) and promotes the binding of Src-family protein-tyrosine kinases (PTKs) to FAK, potentially leading to conformational Src activation (Mitra and Schlaepfer, 2006) . Maximal Src activation requires Tyr-418 phosphorylation within the kinase domain (Roskoski, 2005) . FAK-Src activation leading to p130Cas or paxillin phosphorylation is associated with cell motility , but the molecular controls regulating these events remain loosely defined.
Cellular FN (cFN) contains an alternately spliced region termed connecting segment 1 (CS-1) that binds a4b1 and a4b7 (Pankov and Yamada, 2002) . a4b1 also binds to vascular cell adhesion molecular 1 (VCAM-1) expressed on activated endothelium during inflammation (Rose et al., 2002) . Studies with chimeric a4 integrin subunits showed that the a4 cytoplasmic domain can confer enhanced migratory properties to cells (Chan et al., 1992) and that a4b1 may promote motility through different molecular mechanisms than a5b1 (Mostafavi-Pour et al., 2003) . In mouse fibroblasts, we previously showed that human a4 expression can create a functional a4b1 pair and promote cell motility through Src activation (Hsia et al., 2005) . However, it remains unclear whether endogenous a4 motility-promoting signals occur through similar or distinct mechanisms (Huttenlocher, 2005) .
Here, we show that a4 integrin is expressed in latestage NB tumors and on a variety of human NB cells. We evaluate NB motility and PTK activation to cFN and to specific recombinant FN ligands for a4b1 or a5b1. We find that a4b1-stimulated NB cell motility requires Src but not FAK whereas FAK expression and activity are required to promote a5b1-stimulated NB motility. As recombinant FAK can phosphorylate Tyr-418 within the Src kinase domain, our studies also provide a novel mechanism of direct FAK-mediated Src activation.
Results
a4 and a5 integrins are expressed in late-stage tumors and promote NB cell motility NB is derived from neural crest cell progenitors and the a4-subunit enhances neural crest motility and survival (Kil et al., 1998; Testaz and Duband, 2001 ). Staining of ) and anti-b1 mAb (P4C10, 10 mg ml
À1
). *Values are means7s.d. of triplicates from two separate experiments.
a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al NB tumors with anti-a4 or anti-a5 antibodies revealed their presence in late but not early-stage NB tumors whereas an NB marker (anti-disialoganglioside, GD2) was detected in all tumor samples (Figures 1a and b) . Flow cytometry analyses were performed to determine whether a4 expression is maintained in cell lines derived from various tumors (Table 1) . a4 surface expression was variable with high expression found in NB cells isolated from metastatic tumor sites and low or no a4 expression found in cells from local-regional or more differentiated tumors (Nai-Kong Cheung, unpublished results). NB8 cells with high a4, a5 and b1 expression, and SKNAS cells with high levels of b1, moderate levels of a4 and a5 expression were selected for further investigation ( Figure 1c ). Haptotaxis motility assays of NB8 and SKNAS cells revealed that neutralizing antibodies to a4 or a5 inhibited cell migration 70-80 and 40-60% respectively, whereas a blocking antibody to b1 completely inhibited cFN-stimulated motility. Combined addition of anti-a4 and anti-a5 antibodies blocked cell migration (Figure 1d ) supporting the notion that a4b1 and a5b1 are the primary mediators of NB8 and SKNAS motility on cFN. Glutathione-S-transferase (GST) fusion proteins encompassing FN-(9-11) or FN-(CS-1) (Figure 2a ) can serve to selectively activate either a5b1 or a4b1, respectively (Hsia et al., 2005) . NB8 and SKNAS motility on FN-(9-11) was blocked by addition of anti-a5 or anti-b1, but not anti-a4 antibodies (Supplementary Figures S1a-d) , whereas cell motility on FN-(CS-1) was blocked by addition of anti-a4 or anti-b1, but not anti-a5 antibodies (Supplementary Figures S1a-c, e) .
a5b1-stimulated NB motility on FN-(9-11) was reduced by an inhibitor to Src (PP2) and by expression of FRNK (Figure 2b ), a dominant-negative inhibitor of FAK (Parsons, 2003) . No effects were observed with a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al treatment of cells with the Src-inactive PP3 compound or by equal expression of FRNK S1034 (Hsia et al., 2005) , which does not bind paxillin nor co-localize with integrins. Notably, FN-(CS-1) NB motility was inhibited by PP2 but not by FRNK expression (Figure 2c ). cFN-stimulated NB cell motility was inhibited by PP2 and only slightly reduced by FRNK expression (Figure 2d ). This lack of an effect of FRNK on cFN motility was associated with only minor inhibitory effects on FAK tyrosine phosphorylation ( Figure 2e , left panel). In contrast, FRNK potently blocked FN-(9-11)-stimulated FAK tyrosine phosphorylation ( Figure 2e , right panel), consistent with FRNK inhibition of FN-(9-11) motility. These results support the importance of Src but not necessarily FAK activity for a4b1-initiated NB cell motility and FAK-Src signaling for a5b1-mediated NB cell migration.
a4b1 promotes Src-dependent p130Cas tyrosine phosphorylation To elucidate signaling changes associated with a4b1-mediated NB cell motility, NB8 cells were plated onto FN-(CS-1) and analysed by anti-phosphotyrosine (pY) blotting ( Figure 3a ). Strong phosphorylation of 120-130 kDa proteins was detected and this was blocked by PP2 addition but not by FRNK expression. Analysis of FAK showed no Tyr-397 phosphorylation differences between FRNK-expressing and control cells plated onto FN-(CS-1) ( Figure 3a ). PP2 treatment inhibited Src activation as measured by phospho-specific blotting to Y418 and PP2 treatment also potently inhibited p130Cas adapter protein tyrosine phosphorylation ( Figure 3b ). FRNK overexpression did not effect Src pY418 or p130Cas tyrosine phosphorylation upon NB8 plating on FN-(CS-1). These results are consistent with a4b1-stimulated Src activation promoting p130Cas phosphorylation and motility in a FAK-independent manner. To evaluate the signaling roles of FAK, Src, p130Cas and paxillin in a4b1-stimulated NB cell migration, lentiviral short-hairpin RNA (shRNA) was used to stably knockdown these signaling proteins in NB8 cells (Figure 4a ). Greater than 95% reduction in FAK and paxillin expression and B80% reduction in p130Cas and Src expression was achieved in pooled populations of cells with no significant changes in cell shape ( Figure 4b ). Whereas no compensatory increase in Pyk2 was detected in FAK shRNA NB8 cells, elevated levels of Hic5 were found in paxillin shRNA NB8 cells (Figure 4c ). No differences in either HEF1 or Fyn expression were detected in p130Cas or Src shRNAexpressing cells, respectively (data not shown). Notably, NB8 motility to FN-(CS-1) was inhibited by p130Cas and Src shRNA, while FAK or paxillin shRNA had no impact ( Figure 4d ). NB8 motility to FN-(9-11) was inhibited by p130Cas, Src and FAK shRNA expression ( Figure 4e ).
To verify the importance of p130Cas (Cas) in a4b1-stimulated cell migration, studies were performed with CasÀ/À and reconstituted mouse embryonic fibroblasts (MEFs) expressing equivalent levels of a5 and b1 but no endogenous a4 ( a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al versus 37715%) and this was associated with 2.7-fold elevated motility on FN-(CS-1) (Supplementary Figure  S2d) . Together with the NB8 shRNA data, these results support the notion that Src and Cas expression are important for both a4b1 and a5b1 motility-promoting signaling whereas FAK is required for a5b1 but not a4b1-stimulated NB8 cell migration.
FAK promotes a5b1-stimulated Src activation and Src Y418 phosphorylation To confirm that FAK is selectively required for a5b1-but not a4b1-stimulated NB8 cell migration, murine WT or kinase dead (KD) HA-tagged FAK were transiently expressed in NB8 FAK shRNA cells (Figure 5a) . Surprisingly, both FAK constructs were phosphorylated at Y397 as detected by phospho-specific blotting and formed a complex with Src ( Figure 5a ). In vitro kinase (IVK) assays (Figure 5b ) revealed that KD-FAK remained unphosphorylated at Y397 in the presence of ATP. However, addition of either purified recombinant FAK kinase domain (GST-FAK 411-686) or full-length His-tagged Src (Supplementary Figure S3) promoted KD-FAK phosphorylation at Y397 (Figure 5b ). This result shows that KD-FAK can serve as a substrate for FAK and Src. Expression of WT-FAK in NB8 FAK shRNA cells promoted >8-fold increased motility to FN-(9-11) compared with Lac-Z-expressing cells whereas KD-FAK-expressing cells remained non-motile (Figure 5c ). Neither WT-FAK nor KD-FAK significantly affect NB8 motility on FN-(CS-1). When plated on FN (9-11), only low levels of Src Y418 phosphorylation were detected in NB8 FAK shRNA cells (Figure 5d ). WTbut not KD-FAK promoted Src Y418 phosphorylation ( Figure 5d ) and Src IVK activation (data not shown) on FN-(9-11) ( Figure 6d ). Alternately, Src was equally activated upon FAK shRNA NB8 cells plating on FN-(CS-1) with WT-or KD-FAK re-expression (Figure 5d ). These results show that FAK catalytic activity is required for a5b1-stimulated Src activation and motility whereas FAK is not required for a4b1 connections to Src and migration.
As both WT-and KD-FAK can form a complex with Src, but only WT-FAK functions to promote Src activation upon FN-(9-11) binding, the FAK catalytic domain was used to determine whether it could directly phosphorylate Src (Figure 5e ). To avoid complications of intrinsic Src phosphorylation, kinase-inactive (K297M) Src was expressed in SYF fibroblasts. As analysed by anti-pY418 Src blotting after an IVK assay, the FAK kinase domain strongly promoted Src Y418 phosphorylation (Figure 5e ). Thus, FAK-Src activation following a5b1-mediated cell binding may be initiated in part by FAK phosphorylation of and enhancement of Src catalytic activity.
Compensatory motility mechanisms for FAK shRNA cells on cFN
To evaluate the motility responses of shRNA-expressing NB8 cells on a natural ligand, random motility analyses and time-lapse imaging were performed with cells plated on cFN (Figure 6a ). Cell tracking analyses confirmed that NB8 motility on cFN was inhibited by p130Cas and Src shRNA but not by FAK shRNA expression (Figure 6a ). The lack of FAK shRNA effects on cFN motility contrasts with the partial inhibitory effects of a5 antibody addition for cFN NB8 motility (Figure 1d ). Compared to parental NB8 cells (Figure 1a) , FAK shRNA cells expressed lower levels of a5 but similar levels of a4 and b1 (Figure 6b) . Notably, FAK shRNA cell motility was blocked by anti-a4 and anti-b1 but not by anti-a5 antibodies (Figure 6c ), indicating that FAK shRNA-expressing NB8 cell motility on cFN was mediated by a4b1. Reduced FAK expression had no a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al effect on cFN-stimulated Cas tyrosine phosphorylation (Figure 6d ) whereas in Src shRNA NB8 cells, Cas phosphorylation upon cFN binding was dramatically reduced (Figure 6e) . Thus, a5 expression may be regulated by FAK and NB8 FAK shRNA motility on cFN is associated with a4b1-stimulated and Src-associated Cas tyrosine phosphorylation.
The a4 cytoplasmic domain promotes a4b1-stimulated NB8 motility and Src activation To identify whether the a4 cytoplasmic domain is required for cell motility and PTK activation, NB8 cells were sorted to create a a4-null cell population and in parallel, a4 expression was reduced by lentiviral shRNA (Supplementary Figure S4a ). Loss of a4 expression in NB8 cells impaired motility to cFN, prevented motility to FN-(CS-1), but did not affect motility on FN-(9-11) (Supplementary Figure S4b) . Decreased cFN-stimulated motility was not associated with altered binding and NB8 cells lacking a4 did not bind to FN-(CS-1) (Supplementary Figure S4c) .
To determine whether the motility-defective phenotype of a4-null and a4 shRNA cells on FN-(CS-1) was specifically due to a4 loss, wild-type human a4 (Ad-a4 WT) was transiently re-expressed (Figure 7a ). Re-expression of a4 WT rescued cell motility on FN-(CS-1) (Figure 7b ), whereas equivalent expression of cytoplasmic domain-truncated a4 (Ad-a4 DCyto) promoted a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al adhesion to FN-(CS-1) (data not shown) but did not promote cell motility to FN-(CS-1) (Figure 7b ). When NB8 cells were plated onto FN-(CS-1), re-expression of a4 WT promoted Src Y418 phosphorylation equal to control NB8 cells whereas a4 DCyto only weakly activated Src (Figure 7c) . Thus, the a4 cytoplasmic domain is required to activate Src and plays a critical role in promoting a4b1-mediated NB motility.
PTPa facilitates a4b1-stimulated Src activation, cell spreading and motility As Src activation is accompanied by dephosphorylation of the C-terminal regulatory Tyr-529 site, and Src Tyr-529 is dephosphorylated by PTPa during FN-stimulated fibroblast migration (Zeng et al., 2003) , we tested whether overexpression of WT or a catalytically defective (C433S/ C723S) double mutant (DM) of PTPa could influence a4b1-stimulated NB8 cell motility (Figure 7d ). DM-PTPa inhibited FN-(CS-1)-stimulated NB8 migration >50% with decreased cell spreading (52711% of LacZ cell area) (Figure 7e ). DM-PTPa expression resulted in elevated Src pY529 phosphorylation and decreased Src IVK activity compared to control and WT-PTPa-overexpressing cells (Figure 7f ). In contrast, WT-PTPa overexpression decreased Src pY529 phosphorylation but did not significantly affect Src catalytic activation (Figure 7f ) or FN-(CS-1) cell motility ( Figure 7d ). As NB8 cells express moderate levels of endogenous PTPa, PTPaÀ/À MEFs and Ad-mediated expression of WT-or DM-PTPa was used to test the importance of PTPa in promoting a4b1-stimulated Src activation and motility ( Supplementary  Figures S5a and b) . When PTPaÀ/À cells expressing a4 were plated onto FN-(CS-1), WT-but not DM-PTPa increased Src Y418 phosphorylation by 38% and decreased Src Y529 phosphorylation by 32% (Supplementary Figure S5c ). Further, WT-but not DM-PTPa promoted enhanced cell spreading on FN-(CS-1) (Supplementary Figures S5d and e) and only WT-PTPa functioned to promote efficient a4b1-stimulated fibroblast motility (Supplementary Figure S5f) . These results suggest that PTPa is involved in promoting a4-mediated Src activation through enhanced Src Y529 dephosphorylation and contributes to a4b1-stimulated motility.
Discussion
Here, we analysed the signaling properties of endogenous a4b1 and a5b1 integrins on NB cells using recombinant ligands to selectively activate a4b1 or a5b1 and find that a5b1-mediated NB8 cell migration required both Src and FAK PTK activities whereas a4b1-stimulated NB8 cell motility required Src but not FAK. Moreover, we identified a novel and overlooked mechanism of direct FAK-mediated Src activation through FAK phosphorylation of Src within the catalytic region at Y418.
Current models of a5b1-stimulated FAK-Src signaling place FAK activation and autophosphorylation at Y397 as a receptor-proximal event (Mitra and Schlaepfer, 2006) . FAK Y397 phosphorylation promotes Src SH2 domain binding to FAK, presumably leading to conformational Src activation with a FAK-Src complex. Alternatively, integrin-regulated dephosphorylation of Src at Y529 can enhance Src activation (Zeng et al., 2003) . In both models, it remains undetermined how maximal Src activation occurs via kinase domain Y418 phosphorylation. Although this may occur via Src autophosphorylation (Roskoski, 2005), we found that Src a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al Y418 phosphorylation only weakly occurred in FAK shRNA NB8 cells after a5b1 stimulation. Re-expression of WT-and KD-FAK formed a complex with Src, but only WT-FAK functioned to promote a5b1-stimulated Src Y418 phosphorylation and cell motility. As recombinant FAK kinase domain could directly phosphorylate Src Y418 in vitro, we conclude that a5b1-stimulated Src activation occurs via direct FAK phosphorylation of Src. As Src has been shown to phosphorylate FAK kinase domain residues Y576/Y577 leading to maximal FAK activation (Calalb et al., 1995) , our results suggest that the formation of a FAK-Src complex after a5b1-stimulation leads to mutual PTK activation through corresponding trans-phosphorylation events.
Although previous studies have implicated integrin b1 in mediating FAK-Src activation after a5b1-stimulation of cells (Mitra and Schlaepfer, 2006) , we find that it is the a4 cytoplasmic domain in combination with b1 a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al which facilitates Src PTK activation in a FAKindependent manner to promote NB8 cell motility. Accordingly, abolishing a4 integrin expression in NB8 cells inhibited motility on cFN, and prevented binding to FN-(CS-1), but did not significantly impact migration on an a5b1-selective ligand FN-(9-11). This suggests that minimal crosstalk exists between a4b1 and a5b1 receptors on NB8 cells. Additionally, knockdown of FAK blocked only a5b1-stimulated NB8 migration whereas knockdown of Src or p130Cas prevented both a4b1-and a5b1-initiated cell motility. Fibroblast reconstitution experiments showed that p130Cas, which binds to both FAK and Src, is needed for both a5b1 and a4b1 cell motility. These NB studies extend results obtained using FAKÀ/À fibroblasts where exogenous human a4 expression was sufficient to form a functional a4b1 receptor that rescued FAKÀ/À cell motility defects (Hsia et al., 2005) , and support the existence of a conserved a4-specific signaling linkage promoting Src activation and cell motility. It is known that integrins can generate intracellular signals through the lateral association with other receptors or the clustering of signaling proteins with integrin cytoplasmic domains (Ruoslahti, 1999) . It is interesting that a4-associated signaling is dependent on the integrity of the a4 cytoplasmic domain. This differs from a5b1-stimulated signaling that is generated through protein binding interactions with the b1 cytoplasmic domain. In a4-null or a4-shRNA NB8 cells, a4b1-stimulated motility and Src activation were rescued by re-expression of wild type but not a cytoplasmic domain-truncated mutant of a4 (a4 DCyto). Our finding that a4 DCyto re-expression in NB8 cells promoted adhesion but not Src activation or motility do not support a dominant role for the b1 subunit within an a4b1 signaling complex.
The most simplistic mechanism for a4 to activate Src is via a direct binding interaction. Nonetheless, pull down assays using a recombinant a4 cytoplasmic domain revealed only a weak binding between a4 and Src (data not shown). However, Src can become partially activated by integrins through the dephosphorylation of the C-terminal regulatory Y529 site mediated via the protein tyrosine phosphatases such as PTPa (Zeng et al., 2003) . The cytoplasmic tails of a integrins, a1 and aL, can associate with T-cell PTP in HeLa cells and with the CD45 PTP in leukocytes, respectively (Geng et al., 2005; Mattila et al., 2005) . We found that overexpression of a catalytically inactive mutant of PTPa inhibited a4-associated Src activation and NB8 cell motility. In complimentary studies, WT PTPa re-expression in PTPaÀ/À MEFs (but not catalytically inactive PTPa) enhanced a4b1-stimulated Src activation, spreading and motility. However, as a4-expressing PTPaÀ/À MEFs partially spread and migrated on FN-(CS-1), PTPa is likely important but not essential for a4-Src-associated cell motility. It remains unclear how a4 facilitates Src Y418 phosphorylation in a FAK-independent manner.
Distinct from the widely expressed a5b1 pair, a4b1 is more selectively expressed in inflammatory, endothelial progenitor and in a subset of tumor cells (Rose et al., 2002) . In addition to cFN, a4b1 binds to VCAM-1 that is upregulated at sites of inflammation and present within the bone marrow; a common site of NB tumor metastasis (Brodeur, 2003) . a4b1 engagement with ligand stimulates cell spreading but does not readily promote cell contraction and mature focal adhesion formation (Chan et al., 1992; Pinco et al., 2002) ; thus potentially permitting rapid changes in cell movement. This differs from a5b1 that promotes both cell spreading and focal contact maturation into stable adhesion structures. Moreover, a5b1 but not a4b1 signaling has been linked to enhanced FN matrix assembly (Chan et al., 1992; Wu et al., 1995; Na et al., 2003) . As FAK has been shown to be a critical signaling component associated with FN matrix assembly (Ilic et al., 2004) , the differential activation of FAK by a5b1 may be a key discriminatory event distinguishing the biological outcomes of a4b1-and a5b1-initiated signaling events.
Materials and methods
Tumor immunostaining NB tumors were obtained at the time of surgery with informed patient/guardian consent and according to the regulations of the Institutional Review Board at Memorial Sloan-Kettering Cancer Center. Tumors were embedded in OCT and cryopreserved. Frozen tissue sections were fixed in 3% paraformaldehyde and processed for mouse Immunoglobulin G (IgG)-specific staining to co-detect either a4 integrin (IgG1, Chemicon MAB1383, Temecula, CA, USA) or a5 integrin (IgG1, Chemicon MAB1969) with anti-GD2 NB marker (IgG3, PHB781) followed by secondary IgG-specific antibodies (flourescein goat anti-mouse IgG1 and rhodamine goat anti-mouse IgG3 from Jackson Immuno Research, West Grove, PA, USA). Draq5 (Alexis Biochemicals, Lausen, Switzerland) was used for nuclear staining. Confocal images were captured using Nikon Eclipse C1 microscope and background fluorescence was determined with tissues stained with only secondary antibodies. Three images were assessed for intensity in the RGB channels using Image J software, and the average intensity was calculated. The ratio of staining in the red and green channels was assessed relative to controls, normalized to blue channel (nuclei) and scored positive based upon a threshold at twice of the sampled background.
Adenovirus production and infection
Recombinant Ad for LacZ, human a4 integrin, cytoplasmic domain-truncated a4 integrin were used as described (Hsia et al., 2005) . FAK WT, FAK R454 KD, FRNK and FRNK S1034 are HA-tagged, cloned into pADtet7 and protein expression was performed as described (Hsia et al., 2005) . Ad-PTPa-WT and Ad-PTPa-DM (C4333S/C723S) were used as described (Chen et al., 2006) . In Ad-LacZ-transduced cells, staining for b-gal activity using X-gal as a substrate revealed LacZ expression in >85% of cells.
Short-hairpin RNAs, lentivirus production and infection
The sequences (see Supplementary Information) used to inhibit human FAK, p130Cas, Src or paxillin expressions were cloned into pLentiLox3.7. For induction of lentiviruses, 293T cells were transfected with plentilox3.7 shRNA construct, CMV-VSVG envelope vector, pMD.G, RSV-Rev and a4b1-and a5b1-stimulated neuroblastoma motility L Wu et al pMDL g/p RRE as described (Hsia et al., 2005) . Integrin a4 shRNA lentivirus was from Sigma (St Louis, MO, USA). Lentivirus-containing media was used to infect NB8 cells in the presence of polybrene (5 mg ml À1 ) for 2 days. Infected cells expressing GFP were obtained by FACS and maintained as a pooled population. a4 shRNA-infected cells were selected with 2 mg ml À1 puromycin for 5 days and maintained as a pooled population.
Cell migration
Haptotaxis motility and random motility were performed as described using MilliCell chambers (Millipore, Billerica, MA, USA, 8 mm pores for fibroblasts and 3 mm pores for NB cells) (Hsia et al., 2005) .
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